Ignite Creation Date:
2024-05-05 @ 4:48 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00312949
Status:
COMPLETED
Last Update Posted:
2015-04-16
First Post:
2006-04-07
Brief Title:
Effectiveness of an Interactive Educational Website for Improving the Quality of Mental Health Care for People With Schizophrenia
Sponsor:
Johns Hopkins Bloomberg School of Public Health
Organization:
Johns Hopkins Bloomberg School of Public Health
Study Overview
Official Title:
Consumer Internet Education About Mental Health Quality
Status:
COMPLETED
Status Verified Date:
2015-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will evaluate the effectiveness of an interactive educational website in enhancing discussions about treatment issues and improving the quality of care for people with schizophrenia
Detailed Description:
Schizophrenia is a disabling mental disorder that causes hallucinations and delusions in those affected by it Research has proven that certain treatment methods are more effective in treating schizophrenia than others However not everyone with schizophrenia responds to treatment in the same way and not all physicians use the same treatment methods Educating individuals with schizophrenia about all treatments available instead of only the treatments they are receiving may improve the quality of care and lead to better correlation between treatment and quality standards This study will evaluate the effectiveness of an interactive educational website in enhancing discussions about treatment issues and improving the congruence between expected quality of treatment and treatment received among people with schizophrenia
Participants in this open label study will be randomly assigned to either use the interactive website or read written materials and watch a video All three sources will contain information about evidence-based treatment recommendations Both groups will complete a brief interview before performing their assigned tasks Upon completion of the interview participants in the written materialsvideo group will be given the reading material and will watch a 20-minute video Participants in the web-user group will sit with a laptop computer answer questions about themselves and their treatment receive feedback on care that may be inconsistent with current recommendations and receive suggestions on how to discuss this with their physicians Participants in clinical settings will be asked to allow their next clinician visit to be audiotaped to assess outcomes A phone interview will be conducted with all participants 2 months following the intervention to assess treatment satisfaction and other outcomes Medical records will be reviewed to collect treatment information 6 months before and after the intervention
Participants in this open label study will be randomly assigned to either use the interactive website or read written materials and watch a video All three sources will contain information about evidence-based treatment recommendations Both groups will complete a brief interview before performing their assigned tasks Upon completion of the interview participants in the written materialsvideo group will be given the reading material and will watch a 20-minute video Participants in the web-user group will sit with a laptop computer answer questions about themselves and their treatment receive feedback on care that may be inconsistent with current recommendations and receive suggestions on how to discuss this with their physicians Participants in clinical settings will be asked to allow their next clinician visit to be audiotaped to assess outcomes A phone interview will be conducted with all participants 2 months following the intervention to assess treatment satisfaction and other outcomes Medical records will be reviewed to collect treatment information 6 months before and after the intervention
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| DSIR 82-SEDR | US NIH GrantContract | None | httpsreporternihgovquickSearchR01MH067189 |
| R01MH067189 | NIH | None | None |